PINC AI?

Introducing the Early Alzheimer’s Disease Patient Care Pathway: A comprehensive resource designed to guide health systems through the intricate process of managing Alzheimer’s Disease. This Pathway, developed in collaboration with healthcare professionals representing geographically diverse IDNs and sponsored by Eisai U.S. Alzheimer’s Disease and Brain Health, can help healthcare organizations ensure the operational readiness and clinical management aspects of Alzheimer’s Disease care are addressed, facilitating an integrated approach to patient care throughout the stages of disease trajectory. Access this resource: https://lnkd.in/eMZ6PVpX #AlzheimersDisease #neurology #earlyAD #Alzheimers

Join us at the National Association of ACOs Fall Conference, October 16-18, in Washington, D.C., to speak with members of our PINC AI? Value-Based Care and PINC AI? Stanson teams. We’ll be chatting about the innovative tech-enabled HCC coding solutions for payers and providers as well as the work coming out of the Population Health Management Collaborative. Stop by Booth K to talk to our teams and click here to learn more:?https://lnkd.in/eqC2KSJG

Real-world data (RWD) and Real-world evidence (RWE) play an important role in helping organizations understand the safety, effectiveness and value of healthcare interventions in everyday practice. RWD usage has seen an uptick with 90 percent of global life sciences executives indicating plans to leverage actionable data for decision-making across a product’s life cycle. Learn how your organization can utilize Premier's?PINC AI? Healthcare Data (PHD) to conduct evidence-based analyses of drugs, devices and disease states and accelerate medical solution development:?https://lnkd.in/ePN4zi-H

Transform your workflow and improve patient outcomes with PINC AI? Stanson's ImagingAssure. Learn more about how revolutionizing the prior authorization process and helping ensure that the right care is delivered faster: https://lnkd.in/eEngGSPe #HealthcareInnovation #AI #PriorAuthorization

Medical device companies are front and center on the innovation scene, developing cutting-edge products and technologies that have the potential to revolutionize patient care. However, the journey from conception to widespread adoption is complicated, and the need for robust, real-world evidence (RWE) to support the safety, efficacy and impact of medical devices is critical. As medical device companies strive to bridge the gap between product development and real-world application, leveraging RWD for RWE generation has emerged as a gamechanger to accelerate clinical research, save money and time, and highlight product value. PINC AI? Applied Sciences' Denise Juliano?and Myla Maloney share their insights in this article, originally published in Medical Tech Outlook - read here:?https://lnkd.in/dWydcExX

Rethinking prior authorizations (PA) is crucial for the healthcare industry right now. Traditional PA processes create delays and friction between providers, payers and patients. PINC AI? Stanson's?tech-enabled platform leverages AI to automate and simplify the prior authorization process, cutting down delays and reducing friction between providers and payers. Discover how integrating tech into the PA process can help streamline workflows and enhance patient care. Learn more:?https://lnkd.in/e4B25XvH

In the dynamic landscape of clinical research, staying on top of emerging trends is paramount for optimizing patient experiences, enhancing trial execution and ensuring high retention rates. Our new on-demand panel discussion delves into the intersection of real-world evidence (RWE), the patient voice and their collective impact on clinical trial methodologies - watch now:?https://lnkd.in/eRHs5fD9 Farah Ahmad, EVERSANA, Christina Brennan, MD, Northwell Health, Myla Maloney, Yosef Khan

Revolutionize your prior authorization process with PINC AI??Stanson’s ImagingAssure! Our cutting-edge technology seamlessly integrates into your existing workflow, delivering faster approvals and reducing administrative burdens. Learn more:?https://lnkd.in/eEngGSPe #PriorAuthorization #AIinHealthCare

Premier Inc.'s PINC AI? Applied Sciences recently partnered with Henry Ford Health, Henry Ford Innovations and Eli Lilly and Company to develop a structure, approach and discussion guide in an effort to obtain learnings and insights from providers to better understand the socioeconomic drivers of health disparities for patients with Ulcerative Colitis (UC). The study showed the following factors as the most prevalent barriers to patients seeking preventative and timely access to care: ? Experiencing lower socioeconomic status ? Long wait times to see doctors for screenings and patient reluctance or difficulty in seeking and accessing healthcare ? Scheduling conflicts and stigma with clinical trial participation ? Financial issues, including insurance coverage and out-of-pocket costs for expensive medications, testing and hospitalization ? Health literacy and a lack of understanding of the chronic nature of UC Because UC may lead to complications that develop over time, become serious or life-threatening, and may require hospitalization or surgery, it is imperative that we work to increase health equity to support better diagnosis, management, and treatment for UC. Read our new white paper to learn more about this study and the results: https://lnkd.in/er8kWdJC

Today marks the beginning of Hispanic Heritage Month, which takes place annually from September 15 through October 15! Join us and our Latin Employees and Allies Employee Resource Group as we recognize the contributions and influence of Hispanic Americans in the United States all month! #HispanicHeritageMonth